FI941920A0 - Menetelmä ja koostumus bioaktiivisten substanssien immunologisen aktiivisuuden määrittämiseksi - Google Patents

Menetelmä ja koostumus bioaktiivisten substanssien immunologisen aktiivisuuden määrittämiseksi

Info

Publication number
FI941920A0
FI941920A0 FI941920A FI941920A FI941920A0 FI 941920 A0 FI941920 A0 FI 941920A0 FI 941920 A FI941920 A FI 941920A FI 941920 A FI941920 A FI 941920A FI 941920 A0 FI941920 A0 FI 941920A0
Authority
FI
Finland
Prior art keywords
bioactive substances
immunological activity
tested
solution
composition
Prior art date
Application number
FI941920A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI941920A7 (fi
FI941920L (fi
Inventor
Anna Inglot
Zofia Blach-Olszewska
Original Assignee
Torf Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Ets filed Critical Torf Ets
Publication of FI941920A7 publication Critical patent/FI941920A7/fi
Publication of FI941920L publication Critical patent/FI941920L/fi
Publication of FI941920A0 publication Critical patent/FI941920A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI941920A 1991-10-26 1992-09-28 Menetelmä ja koostumus bioaktiivisten substanssien immunologisen aktiivisuuden määrittämiseksi FI941920A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances
PCT/EP1992/002228 WO1993008470A1 (en) 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances

Publications (3)

Publication Number Publication Date
FI941920A7 FI941920A7 (fi) 1994-04-25
FI941920L FI941920L (fi) 1994-04-25
FI941920A0 true FI941920A0 (fi) 1994-04-25

Family

ID=8207282

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941920A FI941920A0 (fi) 1991-10-26 1992-09-28 Menetelmä ja koostumus bioaktiivisten substanssien immunologisen aktiivisuuden määrittämiseksi

Country Status (22)

Country Link
US (1) US5543300A (pm)
EP (2) EP0539610A1 (pm)
JP (1) JPH07500905A (pm)
AT (1) ATE153763T1 (pm)
AU (1) AU678343B2 (pm)
BG (1) BG61705B1 (pm)
CA (1) CA2122131A1 (pm)
CZ (1) CZ100494A3 (pm)
DE (3) DE539610T1 (pm)
DK (1) DK0609255T3 (pm)
ES (1) ES2061424T3 (pm)
FI (1) FI941920A0 (pm)
GR (3) GR930300100T1 (pm)
HU (1) HU216863B (pm)
LV (1) LV12140B (pm)
NO (1) NO941444L (pm)
PL (1) PL170592B1 (pm)
RO (1) RO114837B1 (pm)
RU (1) RU2125727C1 (pm)
SG (1) SG72665A1 (pm)
SK (1) SK44094A3 (pm)
WO (1) WO1993008470A1 (pm)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
WO2000016785A2 (en) * 1998-09-23 2000-03-30 Enerkom (Proprietary) Limited Humic acid and its use in the treatment of various conditions
RU2180120C1 (ru) * 2000-07-05 2002-02-27 Научно-исследовательский институт детских инфекций Способ выявления цитокинов
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
RU2226275C2 (ru) * 2002-04-15 2004-03-27 Научно-исследовательский и учебно-методический центр биомедицинских технологий ВИЛАР Способ определения цитотоксического эффекта и ростстимулирующей активности веществ для доклинических испытаний
DE60304989T2 (de) * 2003-02-18 2007-03-29 Clinique La Prairie Research S.A. Zusammensetzungen enthaltend fötales Hämoglobin und bakterielles Endotoxin und fakultativ zusätzliche fötale Leberkomponenten
US7497947B2 (en) * 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
EP2753422A1 (en) 2011-09-07 2014-07-16 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
DE3782958D1 (de) * 1986-02-19 1993-01-21 Imreg Inc Verfahren und mittel zum pruefen eines immunsystems.
ATE77488T1 (de) * 1986-03-06 1992-07-15 Commw Scient Ind Res Org In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
ATE131859T1 (de) * 1991-03-16 1996-01-15 Torf Ets Verfahren zur kontinuierlichen extraction von torf und apparat zur durchführung dieses verfahrens

Also Published As

Publication number Publication date
US5543300A (en) 1996-08-06
HU216863B (hu) 1999-09-28
ES2061424T3 (es) 1997-10-01
HK1002610A1 (en) 1998-09-04
CZ100494A3 (en) 1994-11-16
SK44094A3 (en) 1995-03-08
EP0609255A1 (en) 1994-08-10
LV12140B (lv) 1998-12-20
DE69220078D1 (de) 1997-07-03
PL170592B1 (en) 1997-01-31
DE539610T1 (de) 1993-12-16
AU2650992A (en) 1993-05-21
LV12140A (lv) 1998-09-20
GR940300077T1 (en) 1994-11-30
DK0609255T3 (da) 1997-12-22
JPH07500905A (ja) 1995-01-26
DE609255T1 (de) 1995-06-14
AU678343B2 (en) 1997-05-29
GR930300100T1 (pm) 1993-10-29
RO114837B1 (ro) 1999-07-30
ATE153763T1 (de) 1997-06-15
BG61705B1 (bg) 1998-03-31
HUT69990A (en) 1995-09-28
RU94022481A (ru) 1996-09-27
BG98720A (bg) 1995-07-28
HU9401185D0 (en) 1994-07-28
ES2061424T1 (es) 1994-12-16
CA2122131A1 (en) 1993-04-29
WO1993008470A1 (en) 1993-04-29
NO941444L (no) 1994-06-16
SG72665A1 (en) 2000-05-23
RU2125727C1 (ru) 1999-01-27
FI941920A7 (fi) 1994-04-25
DE69220078T2 (de) 1997-12-04
GR3024457T3 (en) 1997-11-28
EP0539610A1 (en) 1993-05-05
EP0609255B1 (en) 1997-05-28
FI941920L (fi) 1994-04-25
NO941444D0 (no) 1994-04-21

Similar Documents

Publication Publication Date Title
Lampson et al. Purification and characterization of chick embryo interferon
DE58908972D1 (de) Aldimino- oder ketimino-oxy-ortho-tolylacrylsäure-methylester, ihre herstellung und diese enthaltende fungizide.
FI941920A0 (fi) Menetelmä ja koostumus bioaktiivisten substanssien immunologisen aktiivisuuden määrittämiseksi
FI881061A0 (fi) Kompositioner med foerdroejd frigoerelse foer parenteralt bruk och deras anvaendning.
DK235687D0 (da) Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf
ATE144142T1 (de) Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
ATA21888A (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
DE68906735D1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
BG47034A3 (bg) Метод за получаване на 7-//мета-заместени/-пеницилини/- -1-карба-1-детиацефалоспорини
DE3884680D1 (de) Äusseres Membranprotein F von Pseudomonas aeruginosa.
NO893135L (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
BE1003255A5 (fr) Acides (rs)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofurannyl)-acetiques et acides 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzo-furannyl)-acetiques et leurs esters mucoregulateurs et anti-ischemiques et procede pour les preparer.
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
Müller Influence of ionizing radiation on the appearance in the serum of rabbits of humoral factors slowing down cell division
DK113789A (da) Thiosulfinsyrederivater, deres anvendelse til behandling af betaendelsessygdomme samt laegemiddel indeholdende disse stoffer
ATE4216T1 (de) 3-hydrocarbylthio-2-acyloxypropyl 2trimethylammonioethyl phosphate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
DK183788A (da) Fremgangsmaade til foroegelse af levedygtigheden af frysetoerrede, maelkesyreproducerende bakteriekulturkoncentrater
ATE135702T1 (de) Aryl- oder heteroaryl-1-alkyl-pyrrol-2- carbonsäure-derivate, zur behandlung von durch interleukin-1 hervorgerufenen erkrankungen
FR2580648B1 (fr) Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3868302D1 (de) Aether und thioaether mit heilender wirkung, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE13633T1 (de) Verfahren zur herstellung von hochgereinigtem antihaemophiliefaktor.
ATE53384T1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.
JPS62294620A (ja) 細胞増殖抑制因子及びその調製方法